Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)
Taiwan
· Delayed Price · Currency is TWD 54.80
+0.90 (1.67%)
Apr 29, 2026, 1:30 PM CST
TPEX:4747 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 569.77 | 611.42 | 606.71 | 494.67 | 411.49 | Upgrade
|
| Revenue Growth (YoY) | -6.81% | 0.78% | 22.65% | 20.21% | -2.95% | Upgrade
|
| Cost of Revenue | 341.43 | 363.45 | 362.08 | 290.29 | 239.57 | Upgrade
|
| Gross Profit | 228.35 | 247.97 | 244.63 | 204.38 | 171.92 | Upgrade
|
| Selling, General & Admin | 139.28 | 129.21 | 128.45 | 108.45 | 100.72 | Upgrade
|
| Research & Development | 15.96 | 20.76 | 17.27 | 13.25 | 8.92 | Upgrade
|
| Operating Expenses | 155.01 | 149.77 | 145.8 | 122.58 | 109.64 | Upgrade
|
| Operating Income | 73.33 | 98.2 | 98.83 | 81.79 | 62.29 | Upgrade
|
| Interest Expense | -3.75 | -3.51 | -4.6 | -1.06 | -1.08 | Upgrade
|
| Interest & Investment Income | 13.95 | 13.24 | 6.33 | 0.49 | 0.57 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | 0.13 | 0.04 | 0.1 | -0.66 | Upgrade
|
| Other Non Operating Income (Expenses) | -33.84 | 1.09 | 0.28 | 0.21 | 0.83 | Upgrade
|
| EBT Excluding Unusual Items | 49.69 | 109.15 | 100.88 | 81.53 | 61.95 | Upgrade
|
| Gain (Loss) on Sale of Investments | 13.77 | -0.44 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.08 | - | 0.01 | - | -0.01 | Upgrade
|
| Pretax Income | 63.38 | 108.71 | 100.89 | 81.53 | 61.94 | Upgrade
|
| Income Tax Expense | 9.87 | 24.59 | 21.19 | 16.68 | 12.84 | Upgrade
|
| Net Income | 53.51 | 84.12 | 79.7 | 64.85 | 49.1 | Upgrade
|
| Net Income to Common | 53.51 | 84.12 | 79.7 | 64.85 | 49.1 | Upgrade
|
| Net Income Growth | -36.40% | 5.55% | 22.90% | 32.08% | -22.75% | Upgrade
|
| Shares Outstanding (Basic) | 45 | 45 | 36 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 47 | 47 | 38 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | 0.04% | 22.56% | 26.25% | -0.07% | -0.04% | Upgrade
|
| EPS (Basic) | 1.19 | 1.87 | 2.24 | 2.16 | 1.64 | Upgrade
|
| EPS (Diluted) | 1.19 | 1.86 | 2.18 | 2.16 | 1.63 | Upgrade
|
| EPS Growth | -36.20% | -14.69% | 0.88% | 32.52% | -22.75% | Upgrade
|
| Free Cash Flow | 7.66 | 49.68 | 103.84 | 29.98 | 15.06 | Upgrade
|
| Free Cash Flow Per Share | 0.16 | 1.07 | 2.73 | 1.00 | 0.50 | Upgrade
|
| Dividend Per Share | 1.050 | 1.750 | 1.500 | 2.000 | 1.450 | Upgrade
|
| Dividend Growth | -40.00% | 16.67% | -25.00% | 37.93% | -24.48% | Upgrade
|
| Gross Margin | 40.08% | 40.56% | 40.32% | 41.32% | 41.78% | Upgrade
|
| Operating Margin | 12.87% | 16.06% | 16.29% | 16.54% | 15.14% | Upgrade
|
| Profit Margin | 9.39% | 13.76% | 13.14% | 13.11% | 11.93% | Upgrade
|
| Free Cash Flow Margin | 1.34% | 8.13% | 17.11% | 6.06% | 3.66% | Upgrade
|
| EBITDA | 93.67 | 119.17 | 119.94 | 100.06 | 77.57 | Upgrade
|
| EBITDA Margin | 16.44% | 19.49% | 19.77% | 20.23% | 18.85% | Upgrade
|
| D&A For EBITDA | 20.34 | 20.97 | 21.11 | 18.27 | 15.29 | Upgrade
|
| EBIT | 73.33 | 98.2 | 98.83 | 81.79 | 62.29 | Upgrade
|
| EBIT Margin | 12.87% | 16.06% | 16.29% | 16.54% | 15.14% | Upgrade
|
| Effective Tax Rate | 15.58% | 22.62% | 21.00% | 20.46% | 20.73% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.